A reciprocal chromosome translocation (9 and 22), called the Philadelphia chromosome, causes a constitutive activation of the BCR-ABL tyrosine kinase, leading to CML [2–5]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.